Windtree Therapeutics : Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Key Business Updates - Form 8-K

Windtree Therapeutics Reports Fourth Quarter and Year-End 2022
Financial Results and Provides Key Business Updates


WARRINGTON, PA - April 3, 2023-Windtree Therapeutics,... | April 3, 2023

Related Keywords

Ukraine ,Boston ,Massachusetts ,United States ,Republic Of China ,Taiwan General ,Taiwan ,Russia ,Paris ,France General ,France ,Craig Fraser ,Alex Mebazaa ,Monique Kosse ,Exchange Commission ,Company Annual Report On Form ,Lee Pharmaceutical Hk Ltd ,Zhaoke Pharmaceutical Hefei Co ,Company Phase ,Drug Administration ,Exchange Commission On ,Windtree Therapeutics Inc ,Windtree Therapeutics Reports Fourth Quarter ,Provides Key Business ,Windtree Therapeutics ,Chief Executive Officer ,Reverses Disease Induced Changes ,Cardiac Function ,Heart Failure Therapeutics ,Professor Alex Mebazaa ,Pre Cardiogenic Shock ,Fourth Quarter ,Bend Financial ,Annual Report ,Zhaoke Pharmaceutical ,Private Securities Litigation Reform Act ,Nc Stock Exchange ,News ,Information ,Press Release ,Mindtree ,Herapeutics ,Reports ,Fourth ,Quarter ,End ,Financial ,Results ,Rovides ,Key ,Business ,A ,Pril Wint Us97382d4025 ,